FcRL6, a new ITIM-bearing receptor on cytolytic cells, is broadly expressed by lymphocytes following HIV-1 infection

TJ Wilson, RM Presti, I Tassi, ET Overton, M Cella… - Blood, 2007 - ashpublications.org
TJ Wilson, RM Presti, I Tassi, ET Overton, M Cella, M Colonna
Blood, 2007ashpublications.org
Fc receptor–like proteins (FcRLs) are a growing family of molecules homologous to FcγRI.
Whereas all 7 previously reported Fc receptor homologs are expressed by B cells, here we
report a new receptor, FcRL6, that is expressed by cytolytic cells including natural killer (NK)
cells and effector and effector-memory CD8+ T cells. FcRL6 contains a novel cytoplasmic
cysteine-rich motif and recruits SHP-2 through a phosphorylated ITIM, indicating a potential
signaling function in effector lymphocytes. In vitro, FcRL6 does not greatly influence NK-cell …
Abstract
Fc receptor–like proteins (FcRLs) are a growing family of molecules homologous to FcγRI. Whereas all 7 previously reported Fc receptor homologs are expressed by B cells, here we report a new receptor, FcRL6, that is expressed by cytolytic cells including natural killer (NK) cells and effector and effector-memory CD8+ T cells. FcRL6 contains a novel cytoplasmic cysteine-rich motif and recruits SHP-2 through a phosphorylated ITIM, indicating a potential signaling function in effector lymphocytes. In vitro, FcRL6 does not greatly influence NK-cell or CD8+ T-cell–mediated cytotoxicity and has minimal impact on cytokine secretion. However, FcRL6 expression among T lymphocytes is greatly expanded in human immunodeficiency virus type 1 (HIV-1)–infected individuals, and includes not only effector and effector-memory CD8+ T cells but also populations of CD4+ T cells. Expansion of FcRL6-positive lymphocytes is not related to viral load, but is indicative of the dysregulated expansion of terminally differentiated effector lymphocyte populations in response to chronic HIV-1 infection and may serve as an important marker for chronic immune activation and for tracking the generation of effector cells following immune stimulation.
ashpublications.org